News | Heart Valve Technology | April 08, 2019| Jeff Zagoudis, Associate Editor

Mick Jagger Recovering After TAVR Procedure

Celebrity case may boost demand and awareness for heart valve manufacturers

Mick Jagger Recovering After TAVR Procedure

April 8, 2019 — Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic valve valve replacement (TAVR) procedure at a New York hospital.

TAVR is a minimally invasive surgical procedure that repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. The procedure is U.S. Food and Drug Administration (FDA)-approved for people with symptomatic aortic stenosis who are considered an intermediate- or high-risk patient for standard valve replacement surgery.

According to the American Heart Association (AHA), many heart valve problems are first identified by the presence of a “murmur” or sound that can be heard when a healthcare provider listens to the heartbeat with a stethoscope. Some murmurs are harmless, and others can indicate an underlying problem with the valve.

Murmurs may indicate valve problems including:

Once a heart valve begins to affect the heart’s ability to pump blood, it is likely to require a repair or replacement.

Usually valve replacement requires an open heart procedure with a “sternotomy,” in which the chest is surgically separated (opened) for the procedure. The TAVR or TAVI procedures can be done through very small openings that leave all the chest bones in place.

A TAVR procedure is not without risks, but it provides beneficial treatment options to people who may not have been candidates for them a few years ago while also providing the added bonus of a faster recovery in most cases. A patient's experience with a TAVR procedure may be comparable to a balloon treatment or even an angiogram in terms of down time and recovery, and will likely require a shorter hospital stay (average 3-5 days).

The TAVR procedure is performed using one of two different approaches, allowing the cardiologist or surgeon to choose which one provides the best and safest way to access the valve:

  • A transfemoral approach entering through the femoral artery, which does not require a surgical incision in the chest; or
  • A transapical approach using a minimally invasive surgical approach with a small incision in the chest and entering through a large artery in the chest or through the tip of the left ventricle (the apex).

At this time the procedure is reserved for those people for whom an open heart procedure poses intermediate risk. For that reason, most people who have this procedure are in their 70s or 80 and often have other medical conditions that make them a better candidate for this type of surgery.

Wells Fargo analyst Larry Biegelsen suggested in a note to clients that news of Jagger’s procedure may provide a boost in demand and awareness for valve manufacturers. “When celebrities like Mick Jagger undergo a surgical procedure, it tends to shine a light on the underlying disease and raise awareness of the procedure itself because of the publicity it generates,” Biegelsen said in his report per Bloomberg.

In an April 5 tweet, Jagger said, “Thank you everyone for all your messages of support, I’m feeling much better now and on the mend - and also a huge thank you to all the hospital staff for doing a superb job.” The Rolling Stones postponed their planned major North American tour that was set to begin April 20 following the news of Jagger’s health issues.

Read the related article NFL Great Ed White Gets New TAVR Heart Valve at Scripps. Whiote waited several months for a valve replacxement until the FDA cleared TAVR for low risk patients in August so he would not have to undergo surgery.

 

For more information: www.heart.org

Related Content

A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th